Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07152184
What this trial is testing

Study Comparing Antipsychotic Dose Reduction vs. Maintenance Treatment in Patients With Schizophrenia Spectrum Disorder: a Personalized Medicine Approach

Who this might be right for
Patient With Schizophrenia Spectrum DisorderNLM Classification WM 203, Psychology:Schizophrenic PsychologySchizophrenia Spectrum and Other Psychotic Disorders
University Hospital, Strasbourg, France 288
Not applicableEnded earlyNCT00931996
What this trial is testing

Oculomotor and Spatial Cognition Deficits in Schizophrenia

Who this might be right for
Schizophrenia
University of Illinois at Chicago 12
Testing effectiveness (Phase 2)Ended earlyNCT04421456
What this trial is testing

Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment

Who this might be right for
Schizophrenia
Jazz Pharmaceuticals 95
Early research (Phase 1)UnknownNCT00197834
What this trial is testing

Study of Depakote for Behavioral and Psychological Symptoms in Dementia

Who this might be right for
Dementia
Hearthstone Alzheimer Care 20
Post-approval studies (Phase 4)UnknownNCT01300364
What this trial is testing

Reboxetine and Citalopram as an Adjunct Treatment to Second Generation Antipsychotics in the Treatment of Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Fundació Sant Joan de Déu 249
Testing effectiveness (Phase 2)Study completedNCT00561587
What this trial is testing

Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study

Who this might be right for
Alcohol Relapse PreventionAlcoholismAlcohol Drinking+2 more
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 40
Large-scale testing (Phase 3)Study completedNCT01888107
What this trial is testing

Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Janssen-Cilag S.p.A. 347
Not applicableEnded earlyNCT01177709
What this trial is testing

Metformin for Weight Loss in Schizophrenia

Who this might be right for
SchizophreniaObesity
Nathan Kline Institute for Psychiatric Research 12
Large-scale testing (Phase 3)Study completedNCT05690698
What this trial is testing

Quetiapine Versus Haloperidol in the Management of Hyperactive Delirium

Who this might be right for
Hyperactive Delirium
Alexandria University 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT07342764
What this trial is testing

Dapagliflozin Versus Metformin for the Management of Antipsychotic-Induced Weight Gain: A Pragmatic Pilot Randomized Controlled Trial

Who this might be right for
Antipsychotic-induced Weight Gain (AIWG)Antipsychotic-induced Weight Gain
Sultan Qaboos University 110
Post-approval studies (Phase 4)UnknownNCT00157378
What this trial is testing

Optimization of Acute Treatment in First Episode Schizophrenia

Who this might be right for
Schizophrenia, First-Episode
Ludwig-Maximilians - University of Munich 300
Early research (Phase 1)Study completedNCT00821600
What this trial is testing

Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia

Who this might be right for
Psychotic DisordersSchizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 24
Early research (Phase 1)Study completedNCT00791349
What this trial is testing

QT and QTc Intervals in Patients Administered Immediate Release Paliperidone

Who this might be right for
SchizophreniaSchizoaffective Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 141
Testing effectiveness (Phase 2)Ended earlyNCT00617058
What this trial is testing

Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine

Who this might be right for
Weight Gain
University of North Carolina, Chapel Hill 1
Not applicableUnknownNCT03237052
What this trial is testing

Validating and Optimizing Model of Antipsychotics Selection

Who this might be right for
Schizophrenia
Shanghai Mental Health Center 2,000
Not applicableUnknownNCT00330226
What this trial is testing

Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders

Who this might be right for
SchizophreniaBipolar Disorder
Seoul National University Hospital 500
Post-approval studies (Phase 4)Study completedNCT00191555
What this trial is testing

Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment

Who this might be right for
Schizophrenia
Eli Lilly and Company 360
Large-scale testing (Phase 3)WithdrawnNCT00440843
What this trial is testing

Zyprexa and Task Engagement in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
VA Connecticut Healthcare System
Early research (Phase 1)Study completedNCT00796276
What this trial is testing

Paliperidone Enantiomer Disposition With Different Formulations and the Bioavailability of Immediate- and Extended-release Paliperidone

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 20
Post-approval studies (Phase 4)Study completedNCT00391261
What this trial is testing

An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Cambridge Health Alliance 11
Next Page